Nautilus to Measure Proteoforms in ARPA-H-Funded Research Consortium
Nautilus expects to receive up to $6 million to bring its Voyager Platform to a multidisciplinary team developing diagnostics and therapeutics.
Story updates
10:04:22 AM UTC
SquawkNews
Nautilus expects up to $6M over four years to deploy its Voyager platform within ARPA-H’s SEEDS consortium, targeting proteoforms in Alzheimer’s disease and Ewing sarcoma.Material DetailsContext by AI AnalystNautilus remains a development-stage proteomics company seeking validation and early revenu…